{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:48:43Z","timestamp":1772012923569,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11904-007-0017-6","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T16:32:20Z","timestamp":1187368340000},"page":"114-118","source":"Crossref","is-referenced-by-count":34,"title":["Managing HIV peripheral neuropathy"],"prefix":"10.1007","volume":"4","author":[{"given":"Alejandra","family":"Gonzalez-Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Cikurel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,18]]},"reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.58.12.1764","volume":"58","author":"G. Schifitto","year":"2002","unstructured":"Schifitto G, McDermott MP, McArthur JC, et al.: Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 58:1764\u20131768.","journal-title":"Neurology"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","volume":"40","author":"K.A. Lichtenstein","year":"2005","unstructured":"Lichtenstein KA, Armon C, Baron A, et al.: Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005, 40:148\u2013157.","journal-title":"Clin Infect Dis"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000152981.32057.BB","volume":"64","author":"G. Schifitto","year":"2005","unstructured":"Schifitto G, McDermott MP, McArthur JC, et al.: Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 2005, 64:842\u2013848.","journal-title":"Neurology"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0733-8619(18)30204-4","volume":"10","author":"D.M. Simpson","year":"1992","unstructured":"Simpson DM, Olney RK: Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 1992, 10:685\u2013711.","journal-title":"Neurol Clin"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mito.2004.06.007","volume":"4","author":"L. Estanislao","year":"2004","unstructured":"Estanislao L, Thomas D, Simpson D: HIV neuromuscular disease and mitochondrial function. Mitochondrion 2004, 4:131\u2013139.","journal-title":"Mitochondrion"},{"key":"17_CR6","unstructured":"Estanislao L, Morgello S, Dorfman D, et al.: Diagnosis of HIV-associated distal symmetric polyneuropathy in the primary care setting [poster]. Presented at the 5th International Society of Neurovirology HIV Symposium. Baltimore, MD; September 2\u20136, 2003."},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.54.11.2120","volume":"54","author":"C. Martin","year":"2000","unstructured":"Martin C, Solders G, Sonnerborg A, Hansson P: Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology 2000, 54:2120\u20132127.","journal-title":"Neurology"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archneur.1988.00520330023005","volume":"45","author":"Y.T. So","year":"1988","unstructured":"So YT, Holtzman DM, Abrams DI, Olney RK: Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol 1988, 45:945\u2013948.","journal-title":"Arch Neurol"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archneur.61.4.546","volume":"61","author":"S. Morgello","year":"2004","unstructured":"Morgello S, Estanislao L, Simpson D, et al.: HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV brain bank. Arch Neurol 2004, 61:546\u2013551.","journal-title":"Arch Neurol"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.56.1.84","volume":"56","author":"M. Tagliati","year":"1999","unstructured":"Tagliati M, Grinnell J, Godbold J, Simpson DM: Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999, 56:84\u201389.","journal-title":"Arch Neurol"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","volume":"52","author":"E.A. Childs","year":"1999","unstructured":"Childs EA, Lyles RH, Selnes OA, et al.: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999, 52:607\u2013613.","journal-title":"Neurology"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.38.5.794","volume":"38","author":"D.R. Cornblath","year":"1988","unstructured":"Cornblath DR, McArthur JC: Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794\u2013796.","journal-title":"Neurology"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/01.wnl.0000187119.33075.41","volume":"65","author":"C.L. Cherry","year":"2005","unstructured":"Cherry CL, Wesselingh SL, Lal L, McArthur JC: Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 2005, 65:1778\u20131781.","journal-title":"Neurology"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200519040-00005","volume":"19","author":"S. Verma","year":"2005","unstructured":"Verma S, Estanislao L, Simpson D: HIV-associated neuropathic pain: Epidemiology, pathophysiology and management. CNS Drugs 2005, 19:325\u2013334.","journal-title":"CNS Drugs"},{"key":"17_CR15","first-page":"153","volume":"9","author":"D.M. Simpson","year":"1995","unstructured":"Simpson DM, Tagliati M: Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:153\u2013161.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.wnl.0000218303.48113.5d","volume":"66","author":"D.M. Simpson","year":"2006","unstructured":"Simpson DM, Kitch D, Evans SR, et al.: HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006, 66:1679\u20131687.","journal-title":"Neurology"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1529-8027.2001.006001021.x","volume":"6","author":"C.A. Pardo","year":"2001","unstructured":"Pardo CA, McArthur JC, Griffin JW: HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001, 6:21\u201327.","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl2","key":"17_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13550280290167939","volume":"8","author":"D.M. Simpson","year":"2002","unstructured":"Simpson DM: Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol 2002, 8(Suppl 2):33\u201341.","journal-title":"J Neurovirol"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0885-3924(91)90039-7","volume":"6","author":"S. Grond","year":"1991","unstructured":"Grond S, Zech D, Schug SA, et al.: Validation of world health organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991, 6:411\u2013422.","journal-title":"J Pain Symptom Manage"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11904-004-0020-0","volume":"1","author":"S. Verma","year":"2004","unstructured":"Verma S, Estanislao L, Mintz L, Simpson D: Controlling neuropathic pain in HIV. Curr HIV\/AIDS Rep 2004, 1:136\u2013141.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","volume":"51","author":"K. Kieburtz","year":"1998","unstructured":"Kieburtz K, Simpson D, Yiannoutsos C, et al.: A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS clinical trial group 242 protocol team. Neurology 1998, 51:1682\u20131688.","journal-title":"Neurology"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","volume":"251","author":"K. Hahn","year":"2004","unstructured":"Hahn K, Arendt G, Braun JS, et al.: A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004, 251:1260\u20131266.","journal-title":"J Neurol"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","volume":"60","author":"D.M. Simpson","year":"2003","unstructured":"Simpson DM, McArthur JC, Olney R, et al.: Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003, 60:1508\u20131514.","journal-title":"Neurology"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","volume":"6","author":"R.W. Richter","year":"2005","unstructured":"Richter RW, Portenoy R, Sharma U, et al.: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005, 6:253\u2013260.","journal-title":"J Pain"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J. Rosenstock","year":"2004","unstructured":"Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628\u2013638.","journal-title":"Pain"},{"key":"17_CR26","unstructured":"Simpson D, Brown S, Sampson JL: Novel high-concentration capsaicin patch for the treatment of painful HIV-associated distal symmetrical polyneuropathy: results of an open label trial. Presented at the 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; February 8\u201311, 2004."},{"key":"17_CR27","unstructured":"Simpson DM, Brown SJ, Chang S, and the NGX-400 Study Group: Controlled study of high-concentration capsaicin patch for painful HIV-associated distal sensory polyneuropathy. Presented at the 13th Conference on Retroziruses and Opportunistic Infections. Denver, CO; February 5\u20138, 2006."},{"key":"17_CR28","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.aids.0000131354.14408.fb","volume":"18","author":"A.M. Hart","year":"2004","unstructured":"Hart AM, Wilson AD, Montovani C, et al.: Acetyl-L-carnitine: A pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 2004, 18:1549\u20131560.","journal-title":"AIDS"},{"key":"17_CR29","first-page":"250","volume":"2","author":"E. Scarpini","year":"1997","unstructured":"Scarpini E, Sacilotto G, Baron P, et al.: Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. J Peripher Nerv Syst 1997, 2:250\u2013252.","journal-title":"J Peripher Nerv Syst"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2004.08.080","volume":"371","author":"S.C. Keswani","year":"2004","unstructured":"Keswani SC, Leitz GJ, Hoke A: Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett 2004, 371:102\u2013105.","journal-title":"Neurosci Lett"},{"key":"17_CR31","first-page":"147","volume":"159","author":"P.F. Pradat","year":"2003","unstructured":"Pradat PF: Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials. Rev Neurol (Paris) 2003, 159:147\u2013161.","journal-title":"Rev Neurol (Paris)"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-007-0017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-007-0017-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-007-0017-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:15:40Z","timestamp":1559434540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-007-0017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s11904-007-0017-6","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}